2 Results for "

CDK/HDAC-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "CDK/HDAC-IN-3" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-149819
CAS No.: 2944087-54-9
Purity:  99.60%
Target:  

HDAC CDK

Research Areas:  

Cancer

CDK/HDAC-IN-3 is an orally active HDACs/CDKs dual inhibitor. CDK/HDAC-IN-3 has potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2 and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28nM and 82.87 nM. CDK/HDAC-IN-3 can be used for the acute myeloid leukemia (AML) .
loading...
    loading...
Cat. No.: HY-172891
CAS No.: 2197029-81-3
Target:  

CDK HDAC Apoptosis

Research Areas:  

Cancer

CDK9/HDAC1/HDAC3-IN-1 is dual-functional inhibitor of CDK9 and HDAC. CDK9/HDAC1/HDAC3-IN-1 inhibits the protein activity of CDK9/HDAC/HDAC3 with IC50 s of 0.17  μM, 1.73  μM and 1.11 μM for CDK9, HDAC1, and HDAC3, respectively. CDK9/HDAC1/HDAC3-IN-1 inhibits cancer cells by inducing cell apoptosis and cell cycle arrest in the G2/M phase, as well as tumor growth in a murine TNBC MDA-MB-231 xenograft model. CDK9/HDAC1/HDAC3-IN-1 has a broad-spectrum anti-cancer activity, such as breast cancer, cervical cancer, and liver cancer .
loading...
    loading...